Vaccines for COVID-19 may be in the pipeline but how can we ever produce enough to protect the millions at risk? Griffith University could have the answer.
Not only do they have four potential vaccine candidates ready for testing, researchers at Griffith have also pioneered a way of producing them quickly.
Should any prove effective, they’re confident of producing enough to inoculate large numbers of people around the world within weeks.
“The beauty of this platform is unlike many others; we are able to scale up the number of doses manufactured in a short period of time,” says lead researcher Professor Bernd Rehm.
“Should we eventually find a promising vaccine candidate that confers protection, we will be able to mass produce it rapidly
“Our manufacturing partner conceivably could create up to 16 million vaccine doses per week.”
It works via a process of precision engineering, hijacking the natural assembly pathways of microbial cells to create the desired particles.
“We essentially have these microscopic factories assembling these virus-like particles presenting the virus components,” Professor Rehm says.
Once perfected in the lab, the process can be translated into an industrial setting for mass production.
Research to find a vaccine for COVID-19 is only possible if we support our universities. To keep Australia clever, please sign the petition below.